Oral antiangiogenic, powerful and selective inhibitor of tyrosine kinase of endothelial growth factor receptors (VEGFR). Indicated to treat adult patients with advanced renal cells cancer.
Oral antiangiogenic, powerful and selective inhibitor of tyrosine kinase of endothelial growth factor receptors (VEGFR). Indicated to treat adult patients with advanced renal cells cancer.